Halozyme Therapeutics Competitors and Similar CompaniesClear all
Halozyme Therapeutics's competitors and similar companies include Karyopharm Therapeutics, Verastem Oncology, Blueprint Medicines, Agenus, Partner Therapeutics and Rakuten Medical.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Karyopharm Therapeutics Karyopharm Therapeutics is a pharmaceutical company that discovers and develops drugs for the treatment of cancer and other major diseases. |  Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. |  Blueprint Medicines Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders. |  Agenus Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer. |  Partner Therapeutics Partner Therapeutics is developing and commercializing cancer medicines and combination therapies. |  Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies. | |
Founding Date | Founding Date 1998 | Founding Date 2008 | Founding Date 2010 | Founding Date 2011 | Founding Date 1994 | Founding Date 2017 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||||
Locations | Locations San Diego, US HQ | Locations Newton, US HQ Munich, DE Giv'atayim, IL | Locations Needham, US HQ Walsrode, DE | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH | Locations Lexington, US HQ Cambridge, GB Berkeley, US New York, US | Locations Lexington, US HQ Boston, US Lynnwood, US | Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US |
Employees | Employees 1457% increase | Employees 38521% decrease | Employees 4864% decrease | Employees 49515% increase | Employees 32812% increase | Employees 2051% increase | Employees 1371% decrease |
Valuation ($) | Valuation ($) 5.4 b | Valuation ($) 77.8 m | Valuation ($) 162.5 m | Valuation ($) 4.2 b | Valuation ($) 251.9 m | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers 423 | Twitter followers 1.5 k | Twitter followers 2.6 k | Twitter followers 2.8 k | Twitter followers 2.5 k | Twitter followers 147 | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 9 | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) 8 | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 1.8 | Average likes per tweet (last 30 days) 3.2 | Average likes per tweet (last 30 days) 4 | Average likes per tweet (last 30 days) 3.7 | Average likes per tweet (last 30 days) 13.4 | Average likes per tweet (last 30 days) 1.5 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 88.89% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Employee Rating | Employee Rating 3.1 | Employee Rating 3.7 | Employee Rating 4.3 | Employee Rating 4.2 | Employee Rating 3.2 | Employee Rating 4.4 | Employee Rating 2.1 |
Financial | |||||||
Revenue (est.) | Revenue (est.) $660.1m (FY, 2022) | Revenue (est.) $157.1m (FY, 2022) | Revenue (est.) $2.6m (FY, 2022) | Revenue (est.) $204m (FY, 2022) | Revenue (est.) $98m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $139.3m (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods $17.8m (FY, 2022) | Cost of goods $10.6m (FY, 2022) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $520.8m (FY, 2022) | Gross profit N/A | Gross profit N/A | Gross profit $186.2m (FY, 2022) | Gross profit $87.5m (FY, 2022) | Gross profit N/A | Gross profit N/A |
Net income | Net income $202.1m (FY, 2022) | Net income ($165.3m) (FY, 2022) | Net income ($73.8m) (FY, 2022) | Net income ($557.5m) (FY, 2022) | Net income ($230.7m) (FY, 2022) | Net income N/A | Net income N/A |
Operating ⚠ | |||||||
Phase II Trials Products | Phase II Trials Products 1 (FY, 2020) | Phase II Trials Products N/A | Phase II Trials Products 4 (FY, 2020) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A |
Funding | |||||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 60m (over 5 years ago) | Latest funding round $ 100m (over 4 years ago) |
Total funding raised | Total funding raised $ 171.9m | Total funding raised $ 248.7m | Total funding raised $ 170m | Total funding raised $ 1.7b | Total funding raised $ 171.1m | Total funding raised $ 60m | Total funding raised $ 451.9m |
For sources of this data, please see the company profile
View Company Profiles
Karyopharm Therapeutics
HQ
Newton, US
Employees
385↓ 21% decrease
Karyopharm Therapeutics is a pharmaceutical company that discovers and develops drugs for the treatment of cancer and other major diseases.
View companyVerastem Oncology
HQ
Needham, US
Employees
48
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
View companyBlueprint Medicines
HQ
Cambridge, US
Employees
495↑ 15% increase
Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.
View companyAgenus
HQ
Lexington, US
Employees
328↑ 12% increase
Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.
View company